Impact of different stereoisomers of inositol on insulin sensitivity of gestational diabetes mellitus patients

Table 2 Comparison of blood glucose indicators of patients in each group before treatment and after treatment

Group		A, n = 20	B, n = 20	C, n = 20	D, n = 20	F	P value
Fasting glucose in mmol/L	Before treatment	5.52 ± 1.27	5.26 ± 1.23	5.28 ± 1.23	5.25 ± 1.26	0. 2094	0.8896
	After treatment	4.94 ± 1.14	4.97 ± 1.20	4.88 ± 0.99	4.77 ± 1.11	0.1260	0.9444
Two h postprandial glucose in mmol/L	Before treatment	8.52 ± 2.57	8.61 ± 2.25	8.72 ± 2.38	8.89 ± 2.57	0.2764	0.8423
	After treatment	7.87 ± 1.12	5.13 ± 1.40	4.71 ± 1.24	4.69 ± 1.20	30.12	< 0.0001
Glycosylated hemoglobin, %	Before treatment	5.72 ± 2.63	5.63 ± 2.59	5.78 ± 2.53	5.55 ± 2.27	0.0324	0.9921
	After treatment	5.57 ± 1.77	4.93 ± 1.54	4.58 ± 1.44	4.47 ± 1.20	2.178	0.0475
FINS in mmol/L	Before treatment	12.76 ± 1.85	12.97 ± 2.01	12.63 ± 1.73	12.53 ± 1.75	0.2136	0.8867
	After treatment	12.35 ± 1.76	10.56 ± 1.12	9.45 ± 1.71	9.86 ± 0.96	3.154	0.0296
TC in mmol/L	Before treatment	7.26 ± 0.62	7.42 ± 0.71	7.35 ± 0.83	7.25 ± 0.67	0.2553	0.8573
	After treatment	7.12 ± 0.67	5.18 ± 0.45	5.26 ± 0.52	5.33 ± 0.55	56.96	< 0.0001
TG in mmol/L	Before treatment	3.43 ± 0.52	3.31 ± 0.55	3.52 ± 0.64	3.63 ± 0.55	1.147	0.3356
	After treatment	3.13 ± 0.46	2.48 ± 0.48	2.13 ± 0.50	2.39 ± 0.42	16.65	< 0.0001

Data are presented as mean ± standard deviation. FINS: Fasting insulin; TC: Total cholesterol; TG: Triglyceride.